Preclinical Phase Articles & Analysis
25 news found
But the timeline for the development of some vaccine types is still grueling, spanning preclinical design, multiple trial phases, and complex manufacturing hurdles. ...
As of the latest research, several experimental gene therapies for glaucoma are in various stages of development, from preclinical studies to early-phase clinical trials. As an innovative ophthalmic disease research company with a wide range of services in basic research, drug development, and preclinical studies, Ace Therapeutics has expanded ...
Other candidates have already been constructed and are undergoing preclinical evaluation, against HPV induced cancers or infectious diseases. ...
ByOncoVITA
Thomas Englese, a 20+ year industry veteran with a track record of success at leading biopharmaceutical companies, joins as chief commercial officer Marc Lesnick, Ph.D., appointed as chief development officer, bringing more than 20 years of experience in multiple therapeutic areas Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on ADHD, pain and neurological ...
Dirbas will serve as Chair of the SAB, which provides guidance for ongoing preclinical studies as well as ongoing and planned future clinical trials in the use of UNO to treat solid tumors. ...
Funding from the Series B will allow Oligomerix to accelerate its transition into Phase 1 human clinical development planned for early 3Q 2022. Oligomerix closes Series B extension to accelerate transition into Phase 1 human clinical development. ...
Our lead compound, OLX-07010, has demonstrated efficacy in several animal models of neurodegeneration and, upon completion of its preclinical program, will start Phase 1 clinical studies in the first half of 2022. ...
Immunology We have built up over 20 years of expertise in immunology, resulting in a deep and growing pipeline with multiple modes-of-action candidate medicines across all phases of development, from preclinical to Phase 4. We are excited about our selective TYK2 inhibitor, ‘3667, for which we presented new data elucidating its ...
It is highly encouraged to start this forced degradation testing and analysis early in the preclinical phase or phase I of clinical trials. This will help gain sufficient time for identifying degradation products and structure elucidation. ...
(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announces the presentation of preclinical data at the 59th Congress of the European Renal Association (ERA), the largest annual nephrology meeting in Europe, currently held in Paris, France. ...
Multicenter Phase 1 study to evaluate IO-108 as both monotherapy and in combination with pembrolizumab in China Represents the first LILRB2-targeting antibody with IND clearance in China and the company’s fourth IND globally A Phase 1 trial evaluating IO-108 in patients with advanced solid tumors is currently enrolling in the U.S. ...
“We are pleased that Cancer Research UK has successfully completed patient enrollment in the VAC2 Phase 1 clinical study and overcame substantial challenges stemming from the COVID pandemic. ...
Cancer Research UK’s Centre for Drug Development (CDD) is managing and providing significant funding for the phase I/IIa trial. Vaccitech Oncology Limited (VOLT), a strategic collaboration between Vaccitech and Ludwig, are supplying VTP-600 for the trial. ...
The company also secured funding from the Alzheimer’s Drug Discovery Foundation Diagnostics Accelerator to evaluate their device for predictive diagnosis of Alzheimer’s in the preclinical phase, and from Eisai Innovation, a strategic investment organization aspiring to identify synergies between the scientific community and the Eisai network of ...
It follows INOVIO's pre-clinical and Phase 1 trials which suggested to investigators that INO-4201 was well-tolerated and resulted in 100% seroconversion after two doses. "We are excited to begin this Phase 1b trial with our intradermal DNA vaccine candidate INO-4201 as a potential Ebola booster vaccine," said Laurent Humeau, Ph.D., Chief Scientific Officer, ...
Over his long tenure at Pfizer, Bill was responsible for overseeing several clinical development and medical affairs units across multiple therapeutic areas including Pfizer Phase I units. “I am very pleased to take on the role as President, Head of Development & Operations of Oligomerix as we transition from discovery research into a clinically focused ...
(PsiOxus), a clinical stage oncology company re-programming the tumor microenvironment to overcome the central challenge of resistance to therapy, and bluebird bio, Inc. (Nasdaq: BLUE) presented preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2021. ...
reduced neuroinflammation in preclinical animal models. In the phase 2 clinical study of GRF6021 in subjects with PD and cognitive impairment, GRF6021 demonstrated positive effects on cognitive endpoints and was safe and well tolerated by study participants. ...
Vachon joined our management team a few months ago, and his long track record in drug development is already showing great results in accelerating our preclinical achievements and forthcoming clinical development. Working with Dr. ...
Additionally, it provides a pathway for accelerated approval and rolling review of completed Biological Licensing Application sections by the FDA. TVAX Biomedical has completed phase 1/2a studies in multiple cancers, including GBM. Significant efficacy was demonstrated in GBM patients using TVAX’s patented vaccineenhanced adoptive T cell therapy (VACT) in those studies. ...